GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ZYUS Life Sciences Corp (TSXV:ZYUS) » Definitions » Buyback Yield %

ZYUS Life Sciences (TSXV:ZYUS) Buyback Yield % : 27.29 (As of Sep. 22, 2024)


View and export this data going back to 2023. Start your Free Trial

What is ZYUS Life Sciences Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

ZYUS Life Sciences's current buyback yield was 27.29%.


ZYUS Life Sciences Buyback Yield % Historical Data

The historical data trend for ZYUS Life Sciences's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZYUS Life Sciences Buyback Yield % Chart

ZYUS Life Sciences Annual Data
Trend Dec21 Dec22 Dec23
Buyback Yield %
- - -

ZYUS Life Sciences Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -74.83 106.90 - - -

Competitive Comparison of ZYUS Life Sciences's Buyback Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, ZYUS Life Sciences's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ZYUS Life Sciences's Buyback Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ZYUS Life Sciences's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where ZYUS Life Sciences's Buyback Yield % falls into.



ZYUS Life Sciences Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

ZYUS Life Sciences's Buyback Yield for the fiscal year that ended in Dec. 2023 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0) / 63.76266
=0.00%

ZYUS Life Sciences's annualized Buyback Yield for the quarter that ended in Jun. 2024 is calculated as

Buyback Yield=Net Issuance of Stock(Annualized) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) * Annualized Factor / Market Cap
=- (0 + 0) * 4 / 71.555874
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the annualized quarterly data, the Repurchase of Stock and Issuance of Stock data used here is four times the quarterly (Jun. 2024) data.


ZYUS Life Sciences Buyback Yield % Related Terms

Thank you for viewing the detailed overview of ZYUS Life Sciences's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


ZYUS Life Sciences Business Description

Traded in Other Exchanges
Address
407 Downey Road, Unit 204, Saskatoon, SK, CAN, S7N 4L8
ZYUS Life Sciences Corp is a next-generation life sciences company engaged in scientific research and development in phyto-therapeutics, including cannabinoid and protein-based formulations. It is committed to delivering high-quality standardized therapeutic formulations that comply with Good Manufacturing Practices (GMP) to provide targeted relief for patients in Canada and globally.
Executives
John Michael Hyshka Senior Officer

ZYUS Life Sciences Headlines

No Headlines